Neumora Therapeutics, Inc. Common Stock NMRA
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Brian Abrahams | RBC Capital | 1.97 $ | 4 $ | 2.03 % | 02/01/2025 |
| Ami Fadia | Needham | 11.28 $ | 23 $ | 11.72 % | 22/07/2024 |
| Graig Suvannavejh | Mizuho Securities | 10.25 $ | 20 $ | 9.75 % | 08/07/2024 |
| Brian Abrahams | RBC Capital | 9.71 $ | 29 $ | 19.29 % | 17/06/2024 |
| Brian Abrahams | RBC Capital | 14.81 $ | 31 $ | 16.19 % | 13/03/2024 |
| Paul Matteis | Stifel Nicolaus | 10.91 $ | 26 $ | 15.09 % | 10/10/2023 |
| Brian Abrahams | RBC Capital | 10.91 $ | 24 $ | 13.09 % | 10/10/2023 |